Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 56c
Tweet
Share
E-mailGet Alerts SGMT Hot Sheet
Join SI Premium – FREE
Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.32), $0.56 better than the analyst estimate of ($0.88).
For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Gates Industrial launches three new bicycle belt drive sprocket families
- BNY Mellon fund boards retain seats after defeating dissident nominee
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
